The Active Site

BPC-157 is now used as a recovery peptide for tendon injuries, muscle strains, and stubborn joint problems. Some people report remarkable results, while others feel nothing. But its story did not begin in sports medicine. It traces back through human stomach fluid, an old Yugoslav research program, pharmaceutical development, and decades of experiments that still leave major parts of the peptide’s history unresolved. This investigation follows that evidence from the beginning to find out what BPC-157 actually is, what it may be doing, and how it became the healing peptide.
Time stamps:
0:00 – What BPC-157 really is
2:02 – How it got its name
4:50 – What the animal studies show
8:33 – The science that still doesn't add up
10:28 – A stability problem nobody talks about
12:17 – The human trial history
13:43 – A missing piece in the story
15:17 – What the evidence still doesn't prove
16:29 – Where things stand now

BPC-157 is now used as a recovery peptide for tendon injuries, muscle strains, and stubborn joint problems. Some people report remarkable results, while others feel nothing. But its story did not begin in sports medicine. It traces back through human stomach fluid, an old Yugoslav research program, pharmaceutical development, and decades of experiments that still leave major parts of the peptide’s history unresolved. This investigation follows that evidence from the beginning to find out what BPC-157 actually is, what it may be doing, and how it became the healing peptide.
Time stamps:
0:00 – What BPC-157 really is
2:02 – How it got its name
4:50 – What the animal studies show
8:33 – The science that still doesn't add up
10:28 – A stability problem nobody talks about
12:17 – The human trial history
13:43 – A missing piece in the story
15:17 – What the evidence still doesn't prove
16:29 – Where things stand now

Synthetic food dyes were accepted for decades. Now regulators, states, retailers, and manufacturers are moving to remove them from American food.

Why now?

The controversy centers on two alarming claims: cancer and ADHD. This investigation follows both back to their origins, reopens the studies behind them, and asks whether the modern crackdown reflects new scientific evidence or something else entirely.

0:00 – Introduction
1:11 – The 1973 Hunch That Started It All
4:32 – The Hyperactivity Study Everyone Was Waiting For
8:20 – The Flaw No One Noticed
10:11 – A Second Test, a Different Answer
12:13 – Why the FDA Had No Choice
13:53 – The Real Reason Change Is Happening Now
18:47 – What Actually Changed

There is an element sitting in your brain right now, and nobody has established how much you are supposed to have.  It may shape how you think, how you act, and whether your mind holds up as you age. Last year a Harvard lab placed it near the center of Alzheimer's, arguing that running short of it may be one of the first things that goes wrong in the diease. It is already sold as the next longevity compound, the thing that finally protects the aging brain, and the people selling it have a real paper behind them. This investigation takes that case apart study by study to find out how much of it holds. The question sounds simple. The answer, as always, is not.

00:00 – Intro: Lithium and the Brain
01:57 – Lithium's Origin as a Bipolar Drug
04:55 – The Brain Growth Claim
10:10 – Where the Evidence Breaks Down
12:12 – The Harvard Brain Study
15:36 – Should You Take Lithium?
18:04 – New Trial Starting This Fall

Creatine is one of the most-studied supplements in the world, taken by millions of people who have been told for years it is about as safe as anything on the shelf. Then, within weeks of each other, two peer-reviewed studies reached opposite conclusions about what it does to cancer. One found that creatine helped cancer spread faster through the body. The other found that creatine helped the body fight cancer off. Same molecule, serious labs, and results that cannot both be simple. This investigation starts with the alarming study, published only days ago, and takes it apart: what it actually measured, what it measured only in mice, and what it never measured in a human at all. Then it does what the headlines will not, setting that study against the wider body of research to answer the only question that matters for the person taking it. Is creatine feeding cancer, or is something more ordinary going on?
0:00 – Introduction
1:04 – The New Study on Creatine and Cancer
3:22 – Other Studies Findings
6:38 – The Real Explanation
8:41 – A Study on Cancer Patients
9:54 – What's Still Unknown